Skip to main content

Educational only. Detectives Health does not diagnose, treat, or replace professional medical advice.

Detectives Health
Organ Health · Coagulation & Clotting

Understanding How Blood Clots

Blood clotting (haemostasis) is one of the body’s most important protective mechanisms. When a blood vessel is damaged, specialised proteins called clotting factors work together in a carefully controlled sequence to stop bleeding while maintaining normal blood flow.

This educational module explains how clotting works, which laboratory tests assess coagulation and what abnormal results may sometimes indicate — in an educational context only.

Educational information only. Detectives Health explains coagulation laboratory tests in plain English. It does not diagnose bleeding disorders, blood clots or other medical conditions. Please discuss your individual results and symptoms with a qualified healthcare professional.

Understanding haemostasis

How Blood Stops Bleeding

Haemostasis is the coordinated process that stops bleeding after injury. It happens in stages, each involving different components of the blood and blood vessels.

  1. 1 · Blood vessel constriction

    Immediately after injury, the damaged vessel narrows to reduce blood loss. This vasoconstriction is a fast, short-lived response that buys time for the next stages.

  2. 2 · Primary haemostasis — platelet plug

    Platelets recognise the exposed vessel wall, stick to it and to one another, and form a soft temporary plug that seals the injury.

  3. 3 · Secondary haemostasis — fibrin mesh

    Clotting factors activate one another in a controlled sequence (the coagulation cascade), ending with fibrin strands that reinforce the platelet plug into a stable clot.

  4. 4 · Fibrinolysis — clot removal

    Once the vessel wall has healed, the clot is broken down in a controlled way by the fibrinolytic system, restoring normal blood flow.

Vessel injury
Vasoconstriction
Platelet plug
Coagulation cascade
Stable fibrin clot
Simplified educational flow — clots are later removed naturally by fibrinolysis.
The coagulation cascade

Extrinsic, intrinsic and common pathways

The coagulation cascade is often shown as three interconnected pathways. In real biology these pathways overlap, but the simplified view helps explain why different laboratory tests assess different parts of clotting.

Extrinsic pathway

Triggered when tissue factor is exposed after injury outside the blood vessel. This is the pathway assessed most directly by Prothrombin Time (PT) and INR.

Intrinsic pathway

Activated by factors already circulating within the blood. This pathway is assessed by the Activated Partial Thromboplastin Time (APTT).

Common pathway

Both pathways converge here to activate thrombin, which converts fibrinogen into fibrin — the final step that produces a stable clot.

Note: the cascade is deliberately simplified here for learning purposes. Modern coagulation science describes an integrated cell-based model, but the pathway model remains useful for understanding what each laboratory test reflects.

Laboratory tests

Which tests assess coagulation

Each test contributes a small piece of information. Results are always interpreted alongside symptoms, medical history and other investigations.

Prothrombin Time (PT)

What it measures
The time plasma takes to clot via the extrinsic and common pathways once tissue factor is added.
Why it is requested
Commonly requested when assessing bleeding tendency, liver function or before certain procedures.
Typical clinical uses
  • Assessment of unexplained bleeding
  • Evaluation of liver synthetic function
  • Pre-operative screening in certain settings
Open in Blood Test Library

International Normalised Ratio (INR)

What it measures
A standardised way of reporting PT so that results are consistent between different laboratories and reagents.
Why it is requested
Primarily used to monitor people taking warfarin, ensuring the dose keeps clotting within a safe target range.
Typical clinical uses
  • Warfarin dose monitoring
  • Consistency of PT results across laboratories
  • Assessment of severe liver disease

Activated Partial Thromboplastin Time (APTT)

What it measures
The time plasma takes to clot via the intrinsic and common pathways.
Why it is requested
Used to investigate bleeding disorders, monitor unfractionated heparin therapy and detect certain factor deficiencies.
Typical clinical uses
  • Monitoring of unfractionated heparin
  • Assessment of intrinsic pathway factor deficiencies
  • Investigation of prolonged bleeding

Fibrinogen

What it measures
The circulating concentration of fibrinogen, the precursor protein that forms fibrin strands during clotting.
Why it is requested
Reviewed during significant bleeding, in pregnancy assessment, inflammatory conditions and certain liver problems.
Typical clinical uses
  • Assessment of active or major bleeding
  • Inflammation and acute-phase response
  • Support of pregnancy-related assessments

D-Dimer

What it measures
A small protein fragment produced when a fibrin clot is broken down by fibrinolysis.
Why it is requested
Often used, alongside clinical assessment, to help evaluate the likelihood of a blood clot such as deep vein thrombosis or pulmonary embolism.
Typical clinical uses
  • Support of clot exclusion pathways
  • Post-surgical and post-inflammatory monitoring
  • Pregnancy-related assessments (interpreted carefully)
Educational note: A raised D-Dimer does not diagnose a clot on its own. It rises with infection, inflammation, surgery, pregnancy, cancer and increasing age, and must always be interpreted alongside clinical assessment.

Thrombin Time (TT)

What it measures
The time it takes thrombin to convert fibrinogen into fibrin — the final step of the coagulation cascade.
Why it is requested
Used in specialist settings to investigate abnormal clotting, low or abnormal fibrinogen, and the effect of heparin.
Typical clinical uses
  • Detection of heparin effect
  • Assessment of low or abnormal fibrinogen
  • Specialist bleeding investigations
When are these tests requested?

Situations where coagulation tests may be helpful

Healthcare professionals may request coagulation tests to build a fuller picture of bleeding, clotting and anticoagulant treatment. The list below is educational and not exhaustive.

  • Unexplained or prolonged bleeding
  • Easy or unusual bruising
  • Heavy menstrual bleeding
  • Known or suspected liver disease
  • Investigation of blood clotting disorders
  • Monitoring of anticoagulant medication
  • Assessment before certain surgical procedures
  • Disseminated intravascular coagulation (educational context)
  • Inherited clotting disorders (educational context)
Factors that may influence results

Why coagulation results vary

Coagulation values are shaped by many factors, from medication to sample handling. Understanding them helps you and your healthcare professional interpret results in context.

  • Warfarin

    Deliberately prolongs PT/INR; dosing is guided by regular INR monitoring.

  • Heparin

    May prolong APTT and thrombin time depending on type and dose.

  • DOAC medications

    Direct oral anticoagulants can alter results in ways that vary by drug and timing.

  • Liver disease

    Most clotting factors are produced in the liver, so significant liver disease may prolong PT and APTT.

  • Vitamin K intake

    Vitamin K is essential for several clotting factors; low intake or malabsorption may prolong PT.

  • Pregnancy

    Pregnancy naturally shifts fibrinogen, D-Dimer and other clotting values.

  • Acute illness

    Infection and inflammation may transiently alter fibrinogen, D-Dimer and other markers.

  • Sample collection

    Under-filled tubes, delayed processing or contamination can affect coagulation results.

  • Laboratory processing

    Reagents, analysers and calibration all influence measured values; laboratories quality-control every batch.

  • Hydration

    Very poor hydration may alter plasma composition and, indirectly, some measured values.

Symptoms to discuss

Changes worth mentioning to a healthcare professional

These symptoms do not confirm any diagnosis. They are educational prompts for a professional assessment when new, persistent or worsening.

  • • Bleeding gums with normal brushing
  • • Frequent nosebleeds
  • • Large or unexplained bruises
  • • Blood in urine
  • • Blood in stool
  • • Persistent or heavy bleeding after minor cuts
  • • Painful, swollen or red leg
  • • Sudden chest pain
  • • Sudden breathlessness

Seek urgent medical attention

In the UK call 999 for emergencies, or 111 for urgent advice, if you experience severe bleeding or symptoms that may suggest a blood clot, including:

  • • Severe bleeding that will not stop with firm pressure
  • • Sudden chest pain with breathlessness
  • • Sudden weakness, slurred speech or facial droop
  • • Painful, swollen calf — particularly after immobility or long travel
  • • Coughing up blood or vomiting blood
Related laboratory tests

Tests often reviewed alongside coagulation

Frequently asked questions

Common educational questions

Q.Why do I need an INR?

INR is a standardised way of reporting Prothrombin Time. It is used mainly to guide warfarin dosing and to ensure results are consistent between different laboratories. Your healthcare team will advise your personal target range.

Q.Why might my APTT be prolonged?

APTT may be prolonged for several reasons, including anticoagulant medication (such as heparin), inherited factor deficiencies, certain autoantibodies or laboratory factors. Interpretation always requires clinical context.

Q.What is D-Dimer?

D-Dimer is a fragment released when a clot is broken down. It rises with clots but also with infection, inflammation, surgery, pregnancy, cancer and age. A raised D-Dimer does not confirm a clot on its own — it is one piece of the picture.

Q.Can dehydration affect clotting tests?

Severe dehydration can alter plasma composition and, indirectly, some clotting values. Everyday variations in hydration usually have limited impact, but very poor hydration should be corrected before repeat testing when clinically appropriate.

Q.Do blood thinners affect these results?

Yes. Warfarin, heparin and DOACs are all designed to alter coagulation. Their effects on PT, INR, APTT and thrombin time depend on the medication, the dose and the timing of the blood sample.

Q.Why are coagulation tests sometimes repeated?

Coagulation is dynamic. Results may be repeated to confirm a finding, to monitor treatment, to reassess after acute illness, or to check that a sample was not affected by pre-analytical factors.

Biomedical Scientist’s insight

Why context matters in every coagulation result

Laboratory coagulation results should never be interpreted in isolation. Biomedical Scientists carefully assess sample quality, analyser performance, quality control and potential pre-analytical factors before results are authorised.

Healthcare professionals then interpret those laboratory results alongside the patient’s symptoms, medical history, medication and clinical assessment — producing a fuller, safer picture than any single number can provide.

Continue learning

Related Detectives Health modules

Developed under Biomedical Science leadership

Steve Diongo

Founder & Scientific Lead · HCPC-Registered Specialist Biomedical Scientist · 15+ years NHS · 20+ years laboratory medicine

This educational module has been developed and reviewed by the Detectives Health Professional Team under the scientific leadership of Steve Diongo, Founder of Detectives Health and HCPC-Registered Specialist Biomedical Scientist. Educational content follows recognised laboratory standards, current scientific evidence and professional best practice.

Reviewed against NHS, NICE, CDC, WHO and USPSTF guidance.

Educational disclaimer. Detectives Health explains coagulation laboratory tests in plain English. This module does not diagnose bleeding disorders, blood clots or other medical conditions, and does not replace professional medical advice.

Always discuss your laboratory results and symptoms with your healthcare professional, who can interpret them alongside your full clinical picture.

Urgent